Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A
Clinical trial NCT06136507 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06136507
- Sponsor
- Hangzhou Gensciences Biopharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-25
- Primary completion
- 2026-12-31
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.